Hemodynamic and serum biochemical alterations associated with intravenous administration of three types of contrast media in anesthetized dogs

American Journal of Veterinary Research

Volumn 69, Issue 10, 2008, Pages 1268-1273

  Pollard, Rachel E ^a   Puchalski, Sarah M ^a   Pascoe, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; IODINATED CONTRAST MEDIUM; IONIC CONTRAST MEDIUM; IOPAMIDOL; IOTALAMATE SODIUM; NITROGEN; NONIONIC CONTRAST MEDIUM; UREA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOG DISEASE; DRUG SAFETY; HEMODYNAMICS; HYPERTENSION; HYPOTENSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TACHYCARDIA; UREA NITROGEN BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CAT DISEASE; COMPUTER ASSISTED TOMOGRAPHY; OUTCOME ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ANESTHESIA; ANIMALS; BILIRUBIN; BLOOD PRESSURE; BLOOD UREA NITROGEN; CONTRAST MEDIA; CREATININE; DOGS; HEART RATE; SYSTOLE; CATS; HYPERSENSITIVITY; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING;

ANIMALIA; CANIS FAMILIARIS;

EID: 56049108833     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.10.1268     Document Type: Article

References (26)

1. Gueant-Rodriguez RM, Romano A, Barbaud A, et al. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des 2006;12:3359-3372.
2. Li A, Wong CS, Wong MK, et al. Acute adverse reactions to magnetic resonance contrast media - gadolinium chelates. Br J Radiol 2006;79:368-371.
3. Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001;11:1267-1275.
4. Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621-628.
5. Thomsen HS, Bush WH Jr. Adverse effects of contrast media: incidence, prevention and management. Drug Saf 1998;19:313-324.
6. Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects. AJR Am J Roentgenol 1989;152:939-944.
7. Morcos SK. Contrast media-induced nephrotoxicity - questions and answers. Br J Radiol 1998;71:357-365.
8. Goldstein HA, Kashanian FK, Blumetti RF, et al. Safety assessment of gadopentetate dimeglumine in US clinical trials. Radiology 1990;174:17-23.
9. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-2362.
10. Walter PA, Feeney DA, Johnston GR. Diagnosis and treatment of adverse reactions to radiopaque contrast agents. Philadelphia: WB Saunders Co, 1986.
11. Ihle SL, Kostolich M. Acute renal failure associated with contrast medium administration in a dog. J Am Vet Med Assoc 1991;199:899-901.
12. Carr AP, Reed AL, Pope ER. Persistent nephrogram in a cat after intravenous urography. Vet Radiol Ultrasound 1994;35:350-354.
13. Kurabayashi T, Ida M, Fukayama H, et al. Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs. Dentomaxillofac Radiol 1998;27:199-202.
14. Hewitt SA, Brisson BA, Sinclair MD, et al. Comparison of cardiopulmonary responses during sedation with epidural and local anesthesia for laparoscopic-assisted jejunostomy feeding tube placement with cardiopulmonary responses during general anesthesia for laparoscopic-assisted or open surgical jejunostomy feeding tube placement in healthy dogs. Am J Vet Res 2007;68:358-369.
15. Dawson P. Cardiovascular effects of contrast agents. Am J Cardiol 1989;64:2E-9E.
16. Heron CW, Underwood SR, Dawson P. Electrocardiographic changes during intravenous urography: a study with sodium iothalamate and iohexol. Clin Radiol 1984;35:137-141.
17. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc In terv Radiol 2001;12:3-9.
18. Tervahartiala P, Kivisaari L, Kivisaari R, et al. Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron 1997;76:96-102.
19. Parvez Z, Rahman MA, Moncada R. Contrast media-induced lipid peroxidation in the rat kidney. Invest Radiol 1989;24:697-702.
20. Yoshioka T, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992;41:1008-1015.
21. Heyman SN, Brezis M, Epstein FH, et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991;40:632-642.
22. Heyman SN, Brezis M, Reubinoff CA, et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401-412.
23. Liss P, Nygren A, Olsson U, et al. Effects of contrast media and mannitol on renal medulla ry blood flow and red cell aggregation in the rat kidney. Kidney Int 1996;49:1268-1275.
24. Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649.
25. Itoh Y, Yano T, Sendo T, et al. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005;97:473-488.
26. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000;11:177-182.